SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Ron Sigourney who wrote (5241)8/17/1998 1:09:00 PM
From: Nancy McKinney  Respond to of 7041
 
Ron,
Thanks for the opinion. I have always had confidence in SGP, because a family member was in their employ after WWII for a number of years; maybe not such a scientific reason, but they were good to their employees.
Nancy



To: Ron Sigourney who wrote (5241)8/17/1998 6:11:00 PM
From: Bradpalm1  Read Replies (1) | Respond to of 7041
 
<<No rational reason to believe the NDA will not be accepted>>

I'm afraid this is wishful thinking, Ron. The Phase III results say otherwise. Of course time will tell but I would say that there's a 3 to 1 chance against FDA acceptance of Vasomax' NDA.

An FDA rejection of the NDA would be the end of Zonagen.

Bradpalm1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News